Fairchem Organics Ltd · NSE:FAIRCHEMOR
Fairchem Organics — Q1 FY2022 Earnings Presentation
14 slides from Fairchem Organics's earnings presentation, August 2021
Slide 1: Earnings Presentation Q1-FY22
Earnings Presentation Q1-FY22
Slide 2: Company at a Glance
Company at a Glance Well entrenched Customer Long lasting Pan Promoted by Fairfax Forward integration Relationships in high India Raw Material India Holdings and to achieve value growth industries sourcing capabilities backed by addition and to like Paint, Inks, with diversified experienced manufact
Slide 3: Company Overview
Company Overview • Fairchem Organics Ltd. (Fairchem) is engaged in the business of manufacturing of Oleo Chemicals and Nutraceuticals, since the last 25 years. Revenue & EBITDA Margin (In Mn) • The company’s key oleo chemical products include Dimer Acid, Linoleic Acid, Palmitic Acid, 23.58% Monomer
Slide 4: Fairchem's Competitive Advantage
Fairchem’s Competitive Advantage Major Player in the Indian Oleo Chemical Market Using Renewable Resources • Processing waste from edible oil refining process to produce high value oleo chemicals giving it price advantage • Enjoy Leadership Position in the industry due to barriers to entry • Focus o
Slide 5: Financial Governance Standards
Financial Governance Standards Invest for long term growth value creation Always be adequately capitalized Not overleverage the balance sheet Secure sources of sustainable raw material supply Invest in backward and forward integration Transparent communications with all the stakeholders Low volatili
Slide 6: Key Financial Highlights
Key Financial Highlights 6
Slide 7: Q1-FY22 Financial Highlights
Q1-FY22 Financial Highlights Q1-FY22 Financial Performance • The revenues for the quarter were impacted due to the second wave of Covid-19 pandemic INR 1,391 Mn INR 328 Mn 23.58% • The company's continuous efforts on manufacturing efficiency Revenue from EBITDA EBITDA Margins mainly on account of de
Slide 8: Q1-FY22 Profit & Loss Statement
Q1-FY22 Profit & Loss Statement PARTICULARS (INR Mn) Q1-FY22 Q1-FY21 Y-O-Y Q4-FY21 Q-O-Q Revenue from Operations 1,391 351 296.3% 1,593 (12.7)% Total Expenses 1,063 307 NA 1,319 (19.4)% EBITDA 328 44 NA 274 19.7% EBITDA Margin 23.58% 12.54% NA 17.20% 638 bps Other Income 4 - NA 3 (33.3)% Depreciatio
Slide 9: Historical Profit & Loss Statement
Historical Profit & Loss Statement PARTICULARS (INR Mn) FY19 FY20 FY21 Q1-FY22 Revenue from Operations 2,499 3,065 3,966 1,391 Total Expenses 2,138 2,581 3,279 1,063 EBITDA 361 484 687 328 EBITDA Margin 14.44% 15.79% 17.32% 23.58% Other Income 43 66 3 4 Depreciation 55 60 66 17 Finance Cost 57 66 68
Slide 10: Historical Balance Sheet
Historical Balance Sheet ASSETS FY19 FY20 FY21 EQUITY AND LIABILITIES FY19 FY20 FY21 Non-Current Assets EQUITY Property, Plant and Equipment 1,108 1,219 1,220 Equity Share Capital 391 130 130 Capital work-in-progress 9 94 295 Instruments entirely equity in nature Right of use assets 44 43 43 Other E
Slide 11: Historical Cash Flow Statement
Historical Cash Flow Statement PARTICULARS (INR Mn) FY19 FY20 FY21 Cash and Cash Equivalents at Beginning of the year 0.2 0.2 0.3 Cash Flow From Operating Activities 342 312 394 Cash Flow from Investing Activities (137) (239) (228) Cash Flow From Financing Activities (205) (73) (166) Net Inc./(Dec.)
Slide 12: Key Financial Highlights
Key Financial Highlights Revenue (In Mn) EBITDA (In Mn) & EBITDA Margin (%) PAT (In Mn) & PAT Margin (%) 5 Year CAGR - 14% 17.32% 11.32% 10.72% 5 Year CAGR -24% 5 Year CAGR - 36% 15.79% 3,966 13.92% 14.44% 8.60% 687 8.00% 425 3,065 11.62% 2,499 347 2,428 484 5.00% 2,039 338 361 215 194 237 91 FY17 F
Slide 13: Capital Markets
Capital Markets 180% Dividend Percentage 160% 140% 35.00% 120% 100% 80% 25.00% 60% 40% 15.00% 15.00% 20% 10.00% 0% -20% Dec-20 Jan-21 Feb-21 Mar-21 Apr-21 May-21 Jun-21 Fairchem Sensex FY17 FY18 FY19 FY20 FY21 Price Data as at June 30th, 2021 INR Shareholding Pattern as on 30th June, 2021 Face Value
Slide 14: Disclaimer
Disclaimer Fairchem Organics Limited Disclaimer: The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that al